Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001339
Filing Date
2025-01-10
Accepted
2025-01-10 21:08:52
Documents
1
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 form4-01112025_020148.html 4  
1 form4-01112025_020148.xml 4 7174
  Complete submission text file 0001415889-25-001339.txt   8616
Mailing Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 646-860-7985
MeiraGTx Holdings plc (Issuer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Zeldin Robert K (Reporting) CIK: 0001745347 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38520 | Film No.: 25524501